Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy.

被引:0
|
作者
Renzulli, Matteo [1 ]
Buonfiglioli, Federica [2 ]
Brocchi, Stefano [1 ]
Conti, Fabio [2 ]
Serio, Ilaria [4 ]
Caraceni, Paolo [2 ]
Foschi, Francesco G. [3 ]
Mazzella, Giuseppe [2 ]
Verucchi, Gabriella [2 ]
Andreone, Pietro [2 ]
Golfieri, Rita [1 ]
Brillanti, Stefano [2 ]
机构
[1] St Orsola Marcello Malpighi Hosp, Dept Diagnost Med & Prevent, Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Bologna, Italy
[4] Osped Faenza, Faenza, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
440
引用
收藏
页码:223A / 224A
页数:2
相关论文
共 50 条
  • [1] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
    Matteo Renzulli
    Federica Buonfiglioli
    Fabio Conti
    Stefano Brocchi
    Ilaria Serio
    Francesco Giuseppe Foschi
    Paolo Caraceni
    Giuseppe Mazzella
    Gabriella Verucchi
    Rita Golfieri
    Pietro Andreone
    Stefano Brillanti
    European Radiology, 2018, 28 : 506 - 513
  • [2] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
    Renzulli, Matteo
    Buonfiglioli, Federica
    Conti, Fabio
    Brocchi, Stefano
    Serio, Ilaria
    Foschi, Francesco Giuseppe
    Caraceni, Paolo
    Mazzella, Giuseppe
    Verucchi, Gabriella
    Golfieri, Rita
    Andreone, Pietro
    Brillanti, Stefano
    EUROPEAN RADIOLOGY, 2018, 28 (02) : 506 - 513
  • [3] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
    Kilany, Shimaa
    Gomaa, Asmaa Ibrahim
    Sabry, Alyaa
    Moaz, Inas
    Ezzat, Sameera
    Badra, Gamal Ahmed
    Waked, Imam
    HEPATOLOGY, 2019, 70 : 321A - 322A
  • [4] Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
    Conti, Fabio
    Buonfiglioli, Federica
    Scuteri, Alessandra
    Crespi, Cristina
    Bolondi, Luigi
    Caraceni, Paolo
    Foschi, Francesco Giuseppe
    Lenzi, Marco
    Mazzella, Giuseppe
    Verucchi, Gabriella
    Andreone, Pietro
    Brillanti, Stefano
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 727 - 733
  • [5] Letter: direct-acting agent therapy and HCV-related Child C cirrhosis
    Braillon, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) : 476 - 476
  • [6] Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
    Virseda-Berdices, Ana
    Brochado-Kith, Oscar
    Diez, Cristina
    Hontanon, Victor
    Berenguer, Juan
    Gonzalez-Garcia, Juan
    Rojo, David
    Fernandez-Rodriguez, Amanda
    Ibanez-Samaniego, Luis
    Llop-Herrera, Elba
    Olveira, Antonio
    Perez-Latorre, Leire
    Barbas, Coral
    Rava, Marta
    Resino, Salvador
    Jimenez-Sousa, Maria Angeles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 719 - 726
  • [7] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Hanafy, Amr Shaaban
    Bassiony, Mohamed A.
    Basha, Mohammad Abd Alkhalik
    HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 165 - 172
  • [8] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Amr Shaaban Hanafy
    Mohamed A. Bassiony
    Mohammad Abd Alkhalik Basha
    Hepatology International, 2019, 13 : 165 - 172
  • [9] Risk factors of development of hepatocellular carcinoma in HCV patients after direct-acting antiviral therapy
    Morimoto, Naoki
    Isoda, Norio
    Miura, Kouichi
    Watanabe, Shunji
    Takaoka, Yoshinari
    Tsukui, Mamiko
    Murayama, Kozue
    Hirosawa, Takuya
    Yamamoto, Hironori
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 156 - 156
  • [10] Hepatocellular carcinoma after direct-acting antiviral therapy for chronic HCV infection: Is it a real risk?
    Dias, Catia
    Duarte-Ribeiro, Filipa
    Pipa, Sara
    Barbosa, Ana Rita
    Mota, Margarida
    Vieira, Fernando Rosas
    IDCASES, 2018, 14